• Explore /
  • Poster
  • / A randomized phase II study evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in biochemically recurrent prostate cancer (BRPC): Immune results.

A randomized phase II study evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in biochemically recurrent prostate cancer (BRPC): Immune results.

Abstract Poster

Authors

null

Emmanuel S. Antonarakis

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD

Emmanuel S. Antonarakis , Adam S Kibel , George Adams , Lawrence Ivan Karsh , Aymen Elfiky , Neal D. Shore , Nicholas J. Vogelzang , John M. Corman , Robert Claude Tyler , Candice McCoy , Yang Wang , Nadeem A. Sheikh , Charles G. Drake

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT01431391

Citation

J Clin Oncol 31, 2013 (suppl; abstr 5016)

DOI

10.1200/jco.2013.31.15_suppl.5016

Abstract #

5016

Poster Bd #

8

Abstract Disclosures

Similar Posters

First Author: Emmanuel S. Antonarakis

First Author: John Nikitas

First Author: Catherine Handy Marshall

First Author: Bridget F. Koontz